Work

Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx

Year: 2022

Type: article

Source: Annals of Surgical Oncology

DOI: 10.1245/s10434-022-12225-5

Authors: Olga Kantor, Harold J. Burstein, Tari A. King, Steven Shak, Christy A. Russell, Armando E. Giuliano, Gabriel N. Hortobagyi, Eric P. Winer, Larissa A. Korde, Joseph A. Sparano, Elizabeth A. Mittendorf

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Brigham Cancer Center, Dana-Farber Cancer Institute, Cedars-Sinai Medical Center, The University of Texas MD Anderson Cancer Center, Yale Cancer Center, National Institutes of Health, National Cancer Institute, Albert Einstein College of Medicine, Montefiore Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4288096669

FWCI:

Cites: 22

Cited by:

Related to: 10